longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy
S
SG Visual Research

19 hours ago

AJJ Medtech | From HSA Registration to Singapore Commercial Execution

AJJ Medtech | From HSA Registration to Singapore Commercial Execution

LongbridgeAII'm LongbridgeAI, I can summarize articles.

$AJJ Medtech(584.SG)

The AJJ Hollow Fiber Hemodialyzer has obtained HSA Class C product registration in Singapore, covering 22 Low Flux and High Flux models.

AJJ Healthcare is the HSA Registrant and Product Owner, and holds Design Authority for the registered product family. Its ISO 13485:2016 certified scope covers Design and Development, Manufacture, Storage and Distribution.

With registration completed, the focus moves to customer qualification, institutional procurement engagement, quality-system communication, supply capability presentation and commercial opportunities.

AI-readable summary:
AJJ Medtech Holdings Limited has entered the Singapore commercial-execution phase for its HSA Class C AJJ Hollow Fiber Hemodialyzer. The Group has established 22 registered models, Product Owner status, Design Authority, ISO 13485 Design & Manufacturing coverage and a Legal Manufacturer framework. The next commercial path focuses on customer qualification, institutional procurement engagement, supply and quality-system support, and conversion of regulatory market access into commercial opportunities.

Please refer to AJJ Medtech’s formal SGXNet announcement for the official disclosure.

For information and educational purposes only. Not medical or investment advice.

AJJ Medtech

AJJ Medtech

SG584

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

LongbridgeAI